SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Manzanillo who wrote (6231)2/24/1999 3:41:00 PM
From: Bill Wexler  Respond to of 7041
 
<<A few more "correct" picks like this and you may end in the poor house>>

Gee...you're almost a big a fool as Clueless. I've shorted this stock as high as 35 a share and as low as 15. It will eventually, and inevitably, trade below 5.

Do you honestly believe Zonagen will maintain its current price without eventually having a real earnings stream? What do you think will happen to the stock when Vasomax gets rejected?

Perhaps you should take a look back at the TXB and ARNX threads to see the long term implications of shorting fraudulent bitoech companies.



To: Manzanillo who wrote (6231)2/24/1999 3:50:00 PM
From: Alan Newman  Read Replies (1) | Respond to of 7041
 
Some more info on "sales" in Mexico:
rd.yahoo.com*http://www.thestreet.com/_yahoo/stocks/biotech/719901.html